Five higher multibeam doses found to be as effective as 20 smaller doses delivered over several weeks
Men undergoing treatment for prostate cancer could be safely exposed to fewer radiotherapy sessions, a big trial has found.
The trial, conducted by the Royal Marsden NHS foundation trust and the Institute of Cancer Research in London, found that radiotherapy doses can be cut by three-quarters, meaning that five higher doses of radiotherapy are just as effective as 20 smaller doses delivered over several weeks.
More Stories
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip
Australians may soon be able to download iPhone apps from outside Apple App Store under federal proposal
Cancer experts warn of coffee enemas and juice diets amid rise in misinformation